Yeku, O. O., Yeku, O. O., Rao, T. D., Laster, I., Kononenko, A., Purdon, T. J., . . . Spriggs, D. (2021). Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition. Frontiers Media S.A.
Chicago Style (17th ed.) CitationYeku, Oladapo O., et al. Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationYeku, Oladapo O., et al. Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.